Welcome to LookChem.com Sign In|Join Free

CAS

  • or

471-47-6

Post Buying Request

471-47-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

471-47-6 Usage

Chemical Properties

Oxamic acid is a white, water-soluble solid. It is the monoamide ofoxalic acid. It can react with metal carbonates to form oxamate. Oxamic acid inhibits lactate dehydrogenase A.

Uses

Oxamic acid is an ozone oxidation product and is used in the synthesis of hydroxybenzimidazoles preparation as potential anti tumor agents targeting human lactate dehydrogenase A.This compound is suitable for lactate dehydrogenase (LDH) related research.

Application

Oxamic acid (OA) has applications in polymer chemistry. It increases the water solubility of certain polymers, including polyester,epoxide, and acrylic upon binding with them. Oxamic acid can be used as a reactant to prepare 6-phenanthridinecarboxamide by direct C-H carbamoylation reaction using ammonium persulfate in DMSO. It can also be used as an organic ligand to prepare functionalized metal oxide nanoparticles for various biological applications. OA along with p-aminobenzoic acid is used to functionalize Au nanoparticles for the development of a sensor to detect Fe3+ ions by the calorimetric method.

Definition

ChEBI: Oxamic acid is a dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxy groups of oxalic acid with ammonia. It has a role as an Escherichia coli metabolite. It is a conjugate acid of an oxamate.

Check Digit Verification of cas no

The CAS Registry Mumber 471-47-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,7 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 471-47:
(5*4)+(4*7)+(3*1)+(2*4)+(1*7)=66
66 % 10 = 6
So 471-47-6 is a valid CAS Registry Number.
InChI:InChI=1/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6)/p-1

471-47-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B20344)  Oxamic acid, 98%   

  • 471-47-6

  • 5g

  • 405.0CNY

  • Detail
  • Alfa Aesar

  • (B20344)  Oxamic acid, 98%   

  • 471-47-6

  • 25g

  • 830.0CNY

  • Detail
  • Alfa Aesar

  • (B20344)  Oxamic acid, 98%   

  • 471-47-6

  • 100g

  • 2911.0CNY

  • Detail

471-47-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name oxamic acid

1.2 Other means of identification

Product number -
Other names carboxy amide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:471-47-6 SDS

471-47-6Relevant articles and documents

Coupled heterogeneous photocatalysis using a P-TiO2-αFe2O3 catalyst and K2S2O8 for the efficient degradation of a sulfonamide mixture

Guzmán-Mar, Jorge L.,Hernández-Ramírez, Aracely,Hinojosa-Reyes, Laura,Mendiola-Alvarez, Sandra Y.,Palomino-Cabello, Carlos,Turnes-Palomino, Gemma

, (2020/03/18)

Phosphorous-doped Ti-Fe mixed oxide (P-TiO2-αFe2O3) catalysts were prepared by the microwave-assisted sol-gel route and characterized using XRD, SEM, N2 physisorption, UV–vis diffuse reflectance, FTIR, and XPS. P-TiO2-αFe2O3 was evaluated during the degradation of a sulfonamide mixture (5 mg/L, each) under visible light. The photocatalytic process was optimized with a face-centered central composite design. Under optimal conditions (0.5 wt% of αFe2O3, pH 10, and 0.75 g/L of catalyst loading), the sulfate radical advanced oxidation process was carried out using 5 mM K2S2O8 (PS). P doping shifted the light absorption of P-TiO2-αFe2O3 in the visible light range owing to substitutional doping, while the coupling of P-TiO2 with α-Fe2O3 enhanced the absorption in the visible range, which resulted in an increase in the lifetime of the charge carriers and in a superior photoactivity of the P-TiO2-αFe2O3 catalyst in comparison to that of TiO2. The mineralization yield of the sulfonamides (SNs) mixture was enhanced in the presence of an electron acceptor (SO4 ? [rad]), allowing nearly 69 % within 300 min with the P-TiO2-αFe2O3/PS system, while P-TiO2-αFe2O3 and K2S2O8 oxidation achieved only 27 % and 21 %, respectively. The biodegradability index was 0.48 using the P-TiO2-αFe2O3/PS system, indicating a less toxic effluent than the original compounds. Recycling tests demonstrated that P-TiO2-αFe2O3 exhibits good stability in activating PS for SNs degradation during three cycles. Two main intermediates (pyrimidine and hydroquinone) and their hydroxylated re-arrangements were detected during the degradation of the SNs by the coupled process. Oxalic, oxamic, sulfonic, and acetic acids were also identified as by-products from the degradation of the SNs.

Metal-, Photocatalyst-, and Light-Free Direct C-H Acylation and Carbamoylation of Heterocycles

Westwood, Matthew T.,Lamb, Claire J. C.,Sutherland, Daniel R.,Lee, Ai-Lan

supporting information, p. 7119 - 7123 (2019/09/03)

Direct C-H acylations and carbamoylations of heterocycles can now be readily achieved without requiring any conventional metal, photocatalyst, electrocatalysis, or light activation, thus significantly improving on sustainability, costs, toxicity, waste, and simplicity of the operational procedure. These mild conditions are also suitable for gram-scale reactions and late-stage functionalizations of complex molecules, including pharmaceuticals, N,N-ligands, and light-sensitive molecules.

Degradation of a veterinary pharmaceutical product in water by electro-oxidation using a BDD anode

Espinoza, C.,Contreras, N.,Berros, C.,Salazar, R.

, p. 2507 - 2511 (2015/02/05)

The electrochemical oxidation (EO) treatment in water of Fantetra, a veterinary drug widely used in Chile, and its components: oxytetracycline hydrochloride, phtalylsulfathiazole and diphenhydramine, has been carried out at constant current using a BDD/Stainless steel system. First, solutions of each drug were electrolyzed following the decay of the absorbance of each compound and total organic carbon abatement. The mineralization of the Fantetra commercial formulation was also studied. An analysis of the degradation by-products was made by high performance liquid chromatography. Thus, during the degradation of each pharmaceutical by the electrochemical oxidation process, aliphatic carboxylic acids were detected prior to their complete mineralization to CO2 and nitrogen ions, while NO3- and NH4+ remain in the treated solution. This is an essential preliminary step towards the applicability of the EO processes for the treatment of wastewater containing pharmaceutical compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 471-47-6